Magnesium Phosphate
Electrolyte Solutions
Sold as Muscle Ice · AM-5 · Heart Liquescence · Ligatend Liquescence · CALCAREA PHOSPHORICA 6X
- Drug class
- Electrolyte Solutions
- Availability
- Over-the-counter
- Routes
- Oral, Sublingual, Topical
- Markets covered
- 1
- Products on record
- 6
- FDA reports (12 mo)
- 83
Overview
Plain-language summary, compiled from the cited regulatory records
Magnesium Phosphate is classified as an electrolyte solution [1]. It is indicated for the temporary relief of minor muscle and joint aches and pains [1]. These claims are based on traditional homeopathic principles and have not been evaluated by regulatory bodies [1].
This ingredient is available under various brand names, including Muscle Ice, CALCAREA PHOSPHORICA 6X, and AM-5 [1]. In the past 12 months, there have been 83 adverse event reports associated with products containing Magnesium Phosphate [2]. The most frequently reported reactions include joint pain (arthralgia), difficulty breathing (dyspnoea), eye pain, general discomfort (malaise), and product use for unapproved indications [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 6 | November 19, 2025 |
USUnited States· FDA
6 products
Uses
** **Claims based on traditional homeopathic principles, not accepted medical evidence. Not FDA evaluated.
How to take
Sources & citations
- [1]FDA DailyMed · 03b6e2a9-f335-4a… · revised June 13, 2024 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.